Lorad of Danbury, CT, will show its latest developments in bothscreen-film and digital mammography in its RSNA booth. On theconventional side, Lorad will introduce M-IV, its newest mammographyplatform and successor to M-III (SCAN 10/11/95). M-IV's high
Lorad of Danbury, CT, will show its latest developments in bothscreen-film and digital mammography in its RSNA booth. On theconventional side, Lorad will introduce M-IV, its newest mammographyplatform and successor to M-III (SCAN 10/11/95).
M-IV's high transmission cellular grid system (HTC) improvescontrast in screen-film mammography at an equal or lower radiationdose than conventional systems, according to Hal Kirshner, presidentof Lorad and ThermoTrex Medical. It should prove particularlyuseful for imaging patients with dense breasts, Kirshner said.HTC will be available as an option on M-IV units.
Lorad will also reveal its latest work in full-view digital mammography.The company will show patient images acquired with a system beingused by Dr. Laurie Fajardo at the University of Virginia.
In addition, the company has adapted its StereoLoc prone digitalbreast biopsy technology for its upright mammography systems.Lorad will also display a line of radiographic equipment beingdeveloped for the firm by Bennett X-Ray, its new sister company.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.